UCB - Daily - Technical analysis published on 08/25/2023 (GMT)
- 218
- 0
- Timeframe : Daily
- - Analysis generated on
- Status : NEUTRAL
Summary of the analysis
Additional analysis
Quotes
UCB rating 81.18 EUR. The price is lower by -0.37% since the last closing with the lowest point at 81.06 EUR and the highest point at 81.38 EUR. The deviation from the price is +0.15% for the low point and -0.25% for the high point.A bearish opening was detected by the Central Gaps scanner. Sellers are trying to impose a bearish trend in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by UCB:
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of UCB indicates that the overall trend is slightly bearish. 57.14% of the signals given by moving averages are bearish. As the signals currently given by short-term moving averages are rather neutral, the slightly bearish trend could return to neutral. The Central Indicators market scanner is currently detecting a bearish signal that could impact this trend:
Bearish price crossover with adaptative moving average 20
Type : Bearish
Timeframe : Daily
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Other results related to technical indicators were also found by the Central Indicators scanner:
RSI indicator is back under 50
Type : Bearish
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Momentum indicator is back under 0
Type : Bearish
Timeframe : Daily
The Central Patterns scanner, which studies chart patterns, resistances and supports, has identified these signals:
Near resistance of channel
Type : Bearish
Timeframe : Daily
Near support of triangle
Type : Bullish
Timeframe : Daily
The presence of a bullish Japanese candlestick pattern detected by Central Candlesticks that could cause a very short term rebound was also detected:
Bullish doji star
Type : Bullish
Timeframe : Daily
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 75.17 | 76.76 | 79.28 | 81.18 | 82.46 | 84.76 | 87.01 |
Change (%) | -7.40% | -5.44% | -2.34% | - | +1.58% | +4.41% | +7.18% |
Change | -6.01 | -4.42 | -1.90 | - | +1.28 | +3.58 | +5.83 |
Level | Major | Minor | Major | - | Intermediate | Minor | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 79.87 | 80.53 | 81.01 | 81.67 | 82.15 | 82.81 | 83.29 |
Camarilla | 81.17 | 81.27 | 81.38 | 81.48 | 81.59 | 81.69 | 81.79 |
Woodie | 79.77 | 80.49 | 80.91 | 81.63 | 82.05 | 82.77 | 83.19 |
Fibonacci | 80.53 | 80.97 | 81.24 | 81.67 | 82.11 | 82.38 | 82.81 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 76.86 | 78.50 | 79.50 | 81.14 | 82.14 | 83.78 | 84.78 |
Camarilla | 79.77 | 80.02 | 80.26 | 80.50 | 80.74 | 80.98 | 81.23 |
Woodie | 76.54 | 78.34 | 79.18 | 80.98 | 81.82 | 83.62 | 84.46 |
Fibonacci | 78.50 | 79.51 | 80.13 | 81.14 | 82.15 | 82.77 | 83.78 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 72.40 | 74.80 | 77.66 | 80.06 | 82.92 | 85.32 | 88.18 |
Camarilla | 79.07 | 79.56 | 80.04 | 80.52 | 81.00 | 81.48 | 81.97 |
Woodie | 72.63 | 74.92 | 77.89 | 80.18 | 83.15 | 85.44 | 88.41 |
Fibonacci | 74.80 | 76.81 | 78.05 | 80.06 | 82.07 | 83.31 | 85.32 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 49.33 | |
MACD (12,26,9): | 0.1900 | |
Directional Movement: | 4.52 | |
AROON (14): | 42.86 | |
DEMA (21): | 81.53 | |
Parabolic SAR (0,02-0,02-0,2): | 80.03 | |
Elder Ray (13): | -0.22 | |
Super Trend (3,10): | 82.37 | |
Zig ZAG (10): | 81.22 | |
VORTEX (21): | 0.9800 | |
Stochastique (14,3,5): | 64.94 | |
TEMA (21): | 81.86 | |
Williams %R (14): | -50.00 | |
Chande Momentum Oscillator (20): | -0.30 | |
Repulse (5,40,3): | -0.4000 | |
ROCnROLL: | 2 | |
TRIX (15,9): | 0.0300 | |
Courbe Coppock: | 2.80 |
MA7: | 81.49 | |
MA20: | 81.19 | |
MA50: | 80.91 | |
MA100: | 82.75 | |
MAexp7: | 81.53 | |
MAexp20: | 81.31 | |
MAexp50: | 81.36 | |
MAexp100: | 81.13 | |
Price / MA7: | -0.38% | |
Price / MA20: | -0.01% | |
Price / MA50: | +0.33% | |
Price / MA100: | -1.90% | |
Price / MAexp7: | -0.43% | |
Price / MAexp20: | -0.16% | |
Price / MAexp50: | -0.22% | |
Price / MAexp100: | +0.06% |
News
Don't forget to follow the news on UCB. At the time of publication of this analysis, the latest news was as follows:
- UCB announces U.S. availability of RYSTIGGO® (rozanolixizumab-noli) for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
- UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis
- UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials
- UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials
- UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
Add a comment
Comments
0 comments on the analysis UCB - Daily